Literature DB >> 32401669

Diffuse large B-cell lymphoma relapse presenting as extensive neurolymphomatosis.

Pankaj Nepal1, Prem P Batchala2, Patrice K Rehm2, Camilo E Fadul3.   

Abstract

A 56-year-old woman with a history of diffuse large B-cell non-Hodgkin lymphoma (DLBCL-NHL) in remission for two years presented with weight loss and multifocal sensory/motor symptoms. Magnetic resonance imaging (MRI) of the neuraxis and whole-body FDG PET/CT led to a diagnosis of secondary neurolymphomatosis (NL). MRI demonstrated extensive thickening and enhancement of multiple cranial nerves and peripheral nerve plexuses with corresponding elevated metabolism on FDG PET/CT. Treatment with chemotherapy resulted in complete response on FDG PET/CT and subsequently she underwent autologous stem cell transplantation. NL is a rare manifestation of lymphoma affecting the peripheral nervous system. Nonspecific neuropathic symptoms make clinical diagnosis difficult. Though nerve biopsy is considered the gold standard, MRI and FDG PET/CT are accepted alternatives for making the diagnosis. We review imaging findings in NL, describe the differential diagnosis, and discuss the limitations of the imaging modalities.

Entities:  

Keywords:  MRI; Neurolymphomatosis; PET/CT; lymphoma; peripheral nervous system

Mesh:

Year:  2020        PMID: 32401669      PMCID: PMC7286191          DOI: 10.1177/1971400920924799

Source DB:  PubMed          Journal:  Neuroradiol J        ISSN: 1971-4009


  16 in total

Review 1.  Neurolymphomatosis of the peripheral nervous system: a case report and review of the literature.

Authors:  Panagiotis A Sideras; John Matthews; S M Nazmus Sakib; Franka Ofikwu; Vadim Spektor
Journal:  Clin Imaging       Date:  2016-08-26       Impact factor: 1.605

2.  Neurolymphomatosis: MRI and (18) FDG-PET features.

Authors:  Anthony Tien Hoe Lim; Danielle Clucas; Christine Khoo; Bimal Kumar Parameswaran; Eddie Lau
Journal:  J Med Imaging Radiat Oncol       Date:  2015-05-13       Impact factor: 1.735

3.  Peripheral neuropathy: differential diagnosis and management.

Authors:  Hend Azhary; Muhammad U Farooq; Minal Bhanushali; Arshad Majid; Mounzer Y Kassab
Journal:  Am Fam Physician       Date:  2010-04-01       Impact factor: 3.292

Review 4.  Peripheral nervous system involvement in lymphomas.

Authors:  Chiara Briani; Andrea Visentin; Marta Campagnolo; Alessandro Salvalaggio; Sergio Ferrari; Tiziana Cavallaro; Renzo Manara; Roberto Gasparotti; Francesco Piazza
Journal:  J Peripher Nerv Syst       Date:  2019-01-08       Impact factor: 3.494

5.  Neurolymphomatosis.

Authors:  Joachim M Baehring; Denise Damek; Emily C Martin; Rebecca A Betensky; Fred H Hochberg
Journal:  Neuro Oncol       Date:  2003-04       Impact factor: 12.300

6.  Accuracy of apparent diffusion coefficients and enhancement ratios on magnetic resonance imaging in differentiating primary cerebral lymphomas from glioblastoma.

Authors:  Shayan Sirat Maheen Anwar; Mirza Zain Baig; Altaf Ali Laghari; Fatima Mubarak; Muhammad Shahzad Shamim; Umaima Ayesha Jilani; Muhammad Usman Khalid
Journal:  Neuroradiol J       Date:  2019-06-12

Review 7.  Beyond the lymph nodes: FDG-PET/CT in primary extranodal lymphoma.

Authors:  Kin Man Sin; Stanton King Dat Ho; Brian Yung Kong Wong; Harry Gill; Pek-Lan Khong; Elaine Yuen Phin Lee
Journal:  Clin Imaging       Date:  2016-11-16       Impact factor: 1.605

8.  Magnetic resonance texture analysis utility in differentiating intraparenchymal neurosarcoidosis from primary central nervous system lymphoma: a preliminary analysis.

Authors:  Girish Bathla; Neetu Soni; Raymondo Endozo; Balaji Ganeshan
Journal:  Neuroradiol J       Date:  2019-02-21

9.  Pathology of Nerve Biopsy and Diagnostic Yield of PCR-Based Clonality Testing in Neurolymphomatosis.

Authors:  Mathilde Duchesne; Olivier Roussellet; Thierry Maisonobe; Nathalie Gachard; David Rizzo; Marine Armand; Karine Viala; Laurence Richard; Manuela Delage-Corre; Arnaud Jaccard; Philippe Corcia; Jean-Michel Vallat; Laurent Magy
Journal:  J Neuropathol Exp Neurol       Date:  2018-09-01       Impact factor: 3.685

10.  FDG-PET/CT in lymphoma.

Authors:  Maria M D'souza; Abhinav Jaimini; Abhishek Bansal; Madhavi Tripathi; Rajnish Sharma; Anupam Mondal; Rajendra Prashad Tripathi
Journal:  Indian J Radiol Imaging       Date:  2013-10
View more
  1 in total

1.  Analysis and evaluation of DRCOP scheme based on polyethylene glycol liposome doxorubicin in patients with diffuse large B-cell lymphoma.

Authors:  Chunyan Liu; Minjuan Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.